Chinese Medical E-ournals Database

Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition) ›› 2023, Vol. 19 ›› Issue (06): 629 -635. doi: 10.3877/cma.j.issn.1673-5250.2023.06.002

Forum

Current research status in effect of gonadotropin-releasing hormone antagonist on endometrial receptivity

Li Wang1, Yueying Wang2, Fen Zhou3, Yukun Guo4, Lina Wei2,()   

  1. 1. School of Clinical Medicine of Jining Medical University, Jining 272000, Shandong Province, China; Key Laboratory of Pregnancy Disorders Research of Jining City, Jining 272000, Shandong Province, China
    2. Key Laboratory of Pregnancy Disorders Research of Jining City, Jining 272000, Shandong Province, China; Department of Reproductive Medicine of Jining No.1 People′s Hospital, Jining 272000, Shandong Province, China
    3. Department of Reproductive Medicine of Jining No.1 People′s Hospital, Jining 272000, Shandong Province, China
    4. School of Clinical Medicine of North Sichuan Medical College, Nanchong 637000, Sichuan Province, China
  • Received:2023-06-22 Revised:2023-11-09 Published:2023-12-01
  • Corresponding author: Lina Wei
  • Supported by:
    National Natural Science Foundation for Youth of China(82101756)

Compared with classical gonadotropin-releasing hormone agonist (GnRH-a) used in the field of assisted reproductive technology (ART), newly developed gonadotropin-releasing hormone antagonist (GnRH-A) in recent years has the following advantages of being more in line with physiological processes of women. ①Shorten the ART treatment cycle. ②Reduced the amount of ART exogenous gonadotropin. ③There is no occurrence of hypogyny symptoms due to the down-regulation of GnRH-a. ④Significantly reduce the incidence of ovarian hyperstimulation syndrome (OHSS). ⑤Significantly reduce cycle cancellation rate.Results of literature studies showed that the clinical pregnancy rate of infertile patients with treatment of GnRH-a and GnRH-A was lower if the GnRH-A protocol was adopted in fresh embryo (3 d embryo) transfer cycles than the GnRH-a protocol, and the difference was statistically significant (P<0.05); however, in the case of frozen embryo transfer, there was no statistically significant difference in pregnancy rate between two protocols (P>0.05). This suggested that the lower pregnancy rate of GnRH-A during the fresh embryo transfer cycle may be caused by the adverse effects of GnRH-A on endometrial receptivity of infertile patients, rather than the reason of ovum quality and embryo development. The speculation that GnRH-A may affect endometrial receptivity is inconclusive so far. The author intends to elaborate the latest research progress on endometrium receptivity related protein expression levels, related molecular expression levels, the effects of related immune cell function and quantity on endometrial thickness and blood flow in women undergoing in vitro fertilization and embryo transfer (IVF-ET) with GnRH-A protocol. The aim is to reveal the mechanism of endometrial receptivity deficiency in infertile patients caused by GnRH-A protocol, so as to find new targets for the treatment of endometrial receptivity deficiency, improve the clinical pregnancy success rate of patients taking GnRH-A protocol, and provide theoretical reference for optimizing the treatment of GnRH-A.

[1]
Zanetti BF, Braga DPAF, Setti AS, et al. Effect of GnRH analogues for pituitary suppression on oocyte morphology in repeated ovarian stimulation cycles[J]. JBRA Assist Reprod, 2020, 24(1): 24-29. DOI: 201910.5935/1518-0557.20190050.
[2]
刘曼曼,管一春,刘文霞,等. 不同促排卵方案对卵巢储备功能减退患者体外受精-胚胎移植结局的影响[J]. 新乡医学院学报2019, 36(6): 529-532. DOI: 10.7683/xxyxyxb.2019.06.007.
[3]
许伟标,蔡喆. 不同促排卵方案对卵巢高反应者体外受精-胚胎移植结局的影响[J]. 中国实用医药2021, 16(15): 99-102. DOI: 10.14163/j.cnki.11-5547/r.2021.15.036.
[4]
Xia M, Zheng J. Comparison of clinical outcomes between the depot gonadotrophin-releasing hormone agonist protocol and gonadotrophin-releasing hormone antagonist protocol in normal ovarian responders[J]. BMC Pregnancy Childbirth, 2021, 21(1): 372. DOI: 10.1186/s12884-021-03849-8.
[5]
Geng Y, Xun Y, Hu S, et al. GnRH antagonist versus follicular-phase single-dose GnRH agonist protocol in patients of normal ovarian responses during controlled ovarian stimulation[J]. Gynecol Endocrinol, 2019, 35(4): 309-313. DOI: 10.1080/09513590.2018.1528221.
[6]
Chen Q, Fan Y, Zhou X, et al. GnRH antagonist alters the migration of endometrial epithelial cells by reducing CKB[J]. Reproduction, 2020, 159(6): 733-743. DOI: 10.1530/REP-19-0578.
[7]
Tempest N, Batchelor E, Hill CJ, et al. Anterior gradient protein 3 and S100 calcium-binding protein P levels in different endometrial epithelial compartments may play an important role in recurrent pregnancy failure[J]. Int J Mol Sci, 2021, 22(8): 3835. DOI: 10.3390/ijms22083835.
[8]
Zhang D, Han M, Zhou M, et al. Down-regulation of S100P induces apoptosis in endometrial epithelial cell during GnRH antagonist protocol[J]. Reprod Biol Endocrinol, 2021, 19(1): 99. DOI: 10.1186/s12958-021-00787-0.
[9]
陈骞. 促性腺激素释放激素拮抗剂对人子宫内膜容受性的影响及其机制研究[D]. 上海:上海交通大学,2016.
[10]
Sini I, Handayani N, Harahap A, et al. Role of three-dimensional Doppler ultrasonography and leukemia inhibitory factor from endometrial secretion in predicting endometrial receptivity in IVF treatment: a pilot study[J]. Arch Gynecol Obstet, 2022, 306(1): 259-265. DOI: 10.1007/s00404-022-06450-2.
[11]
Xu B, Geerts D, Hu S, et al. The depot GnRH agonist protocol improves the live birth rate per fresh embryo transfer cycle, but not the cumulative live birth rate in normal responders: a randomized controlled trial and molecular mechanism study[J]. Hum Reprod, 2020, 35(6): 1306-1318. DOI: 10.1093/humrep/deaa086.
[12]
周云,林燕玲,林坦,等. 促性腺激素释放激素类似物对小鼠种植期子宫内膜白血病抑制因子、同源框基因a10及胞饮突的影响[J]. 中华生殖与避孕杂志2019, 39(2): 103-106. DOI: 10.3760/cma.j.issn.2096-2916.2019.02.004.
[13]
Xu DF, Liu PP, Fan L, et al. GnRH antagonist weakens endometrial stromal cells growth ability by decreasing c-kit receptor expression[J]. Reprod Biol Endocrinol, 2022, 20(1): 29. DOI: 10.1186/s12958-021-00886-y.
[14]
Ashary N, Laheri S, Modi D. Homeobox genes in endometrium: from development to decidualization[J]. Int J Devel Biol, 2020, 64(1-2-3): 227-237. DOI: 10.1387/ijdb.190120dm.
[15]
许定飞. GnRH拮抗剂方案影响人子宫内膜容受性的作用机制研究[D]. 南昌:南昌大学,2022.
[16]
Lv J, Shan X, Yang H, et al. Single cell proteomics profiling reveals that embryo-secreted TNF-α plays a critical role during embryo implantation to the endometrium[J]. Reproduct Sci, 2022, 29(5): 1608-1617. DOI: 10.1007/s43032-021-00833-7.
[17]
Xu B, Zhou M, Wang J, et al. Increased AIF-1-mediated TNF-alpha expression during implantation phase in IVF cycles with GnRH antagonist protocol[J]. Hum Reprod, 2018, 33(7): 1270-1280. DOI: 10.1093/humrep/dey119.
[18]
Wang J, Huang C, Jiang R, et al. Decreased endometrial IL-10 impairs endometrial receptivity by downregulating HOXA10 expression in women with adenomyosis[J]. Biomed Res Int, 2018, 2018: 2549789. DOI:10.1155/2018/2549789.
[19]
Zhu X, Niu Z, Ye Y, et al. Endometrium cytokine profiles are altered following ovarian stimulation but almost not in subsequent hormone replacement cycles[J]. Cytokine, 2019, 114: 6-10. DOI: 10.1016/j.cyto.2018.11.002.
[20]
Zhu L, Aly M, Wang H, et al. Increased natural killer cell subsets with inhibitory cytokines and inhibitory surface receptors in patients with recurrent miscarriage and decreased or normal subsets in kidney transplant recipients late post-transplant[J]. Clin Exp Immunol, 2018, 193(2): 241-254. DOI: 10.1111/cei.13142.
[21]
Xu B, Wang J, Xia L, et al. Increased uterine NK cell numbers and perforin expression during the implantation phase in IVF cycles with GnRH antagonist protocol[J]. Sci Rep, 2017, 7: 39912. DOI: 10.1038/srep39912.
[22]
Sauerbrun-Cutler M, Huber WJ, Krueger PM, et al. Do endometrial natural killer and regulatory T cells differ in infertile and clinical pregnancy patients? An analysis in patients undergoing frozen embryo transfer cycles [J]. Am J Reproduct Immunol, 2021, 85(6): e13393. DOI: 10.1111/aji.13393.
[23]
徐士儒,许健,陈聪,等. GnRH拮抗剂方案对黄体中期子宫内膜免疫细胞数量的影响[J]. 生殖医学杂志2019, 28(12): 1463-1468. DOI: 10.3969/j.issn.1004-3845.2019.12.014.
[24]
Liu H, Zhang J, Wang B, et al. Effect of endometrial thickness on ectopic pregnancy in frozen embryo transfer cycles: an analysis including 17,244 pregnancy cycles[J]. Fertil Steril, 2020, 113(1): 131-139. DOI: 10.1016/j.fertnstert.2019.09.003.
[25]
马丽,刘梦雪. 子宫内膜厚度对体外受精胚胎移植治疗结局的影响探讨?[J]. 中国保健营养2021, 31(1): 41.
[26]
Zhang J, Sun Y, Xu Y, et al. Effect of endometrium thickness on clinical outcomes in luteal phase short-acting GnRH-a long protocol and GnRH-Ant protocol[J]. Front Endocrinol (Lausanne), 2021, 12: 578783.
[27]
Lu Y, Niu Y, Wang Y, et al. Optimal candidates to do fresh embryo transfer in those using oral contraceptive pretreatment in IVF cycles[J]. Front Physiol, 2021, 12. DOI: 10.3389/fphys.2021.576917.
[28]
魏晗,李丹,王磊,等. GnRH拮抗剂方案对新鲜移植周期子宫内膜容受性影响的回顾性分析[J]. 国际生殖健康/计划生育杂志2018, 37(1): 36-40. DOI: 10.3969/j.issn.1674-1889.2018.01.008.
[29]
Masrour MJ, Yoonesi L, Aerabsheibani H. The effect of endometrial thickness and endometrial blood flow on pregnancy outcome in intrauterine insemination cycles[J]. J Family Med Prim Care, 2019, 8(9): 2845-2849. DOI: 10.4103/jfmpc.jfmpc_212_19.
[30]
Yu J, Li B, Li H, et al. Comparison of uterine, endometrial and subendometrial blood flows in predicting pregnancy outcomes between fresh and frozen-thawed embryo transfer after GnRH antagonist protocol: a retrospective cohort study[J]. J Obstet Gynaecol, 2023, 43(1): 2195937. DOI: 10.1080/01443615.2023.2195937.
[1] Shuqin Zhang, Lian Chen. Diagnosis and treatment of postpartum intrauterine retained products of conception[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 493-497.
[2] Jiechun Shi, Ziyu Fan, Yan Xing. Early warning efficiency of different screening methods on cervical adenocarcinoma in situ[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 575-581.
[3] Dan Tang, Xiaoxi Yao, Bowen Yang, Shaolong Xue, Mengyao Li, Liuxing Wei, Mingrong Xi. The impact of doublecortin-like kinase 1 on the clinical characteristics of endometrioid adenocarcinoma patients[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 582-590.
[4] Qingzhuo Gao, Yifan Kang, Zhihong Wang. Current research status of clinical studies on monopronuclear embryos in in vitro fertilization cycles[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(03): 260-265.
[5] Yi Wei, Yuxi Zhou, Ye Yang, Xiufeng Ling, Chun Zhao. Current research status on roles of microRNA on endometrial receptivity[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(03): 266-270.
[6] Lin Lin, Simeng Tian, Yonghua Yu, Feifei Xu, Mingli Huang. Current research status on treatment of intrauterine adhesion by stem cells and their exosomes[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(03): 271-275.
[7] Xin Li, Yi Wei, Juan Zhang, Juanjuan Zhang, Xiufeng Ling, Chun Zhao, Mianqiu Zhang. Influencing factors on clinical pregnancy outcomes of frozen-thaw embryo transfer cycle in women of advanced age[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(03): 276-283.
[8] Lin Yang, Rutie Yin. Current research status on etiology and treatment of patients with white lesions of vulva[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(02): 157-165.
[9] Jie Yuan, Yuqi Qiao, Yandong Li. Efficacy of letrozole combined with metformin and dydrogesterone in treatment of polycystic ovarian syndrome with infertility[J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(04): 343-347.
[10] Wenyan Wang, Jianlan Zheng, Lici Zhu. Clinical study on the risk of pregnancy and perinatal period after in vitro fertilization and embryo transfe[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2024, 13(04): 220-226.
[11] Miao Hu, Lili Du, Lizi Zhang, Lin Lin, Yuliang Zhang, Shifeng Gu, Zhongjia Gu, Siying Lai, Jingying Liang, Yu Liu, Minshan Huang, Yuanyuan Huang, Qingqing Huang, Shijun Luo, Dunjin Chen. A study on placenta accreta grading and perinatal outcomes in patients conceived through in vitro fertilization/intracytoplasmic sperm injection[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2024, 13(03): 183-189.
[12] Ting Li, Yincheng Teng. In vitro fertilization-embryo transfer and placenta previa[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2024, 13(02): 84-87.
[13] Xing Wei, Luming Sun. Assisted reproductive technology and fetal growth disorders[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2024, 13(02): 88-92.
[14] Huiting Zhang, Ling Feng. In vitro fertilization-embryo transfer technology and preterm birth[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2024, 13(02): 73-78.
[15] Shuqin Zhang, Yangyu Zhao. In vitro fertilization-embryo transfer and hypertensive disorder complicating pregnancy[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2024, 13(02): 79-83.
Viewed
Full text


Abstract